Open AccessReduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease
Author(s) -
Lin Lu,
Ya Nan Wang,
Ming Chun Li,
Haibo Wang,
Li Jin Pu,
Wen Quan Niu,
Hua Meng,
Er Li Yang,
Ruiyan Zhang,
Qi Zhang,
Qiang Zhao,
Qiujing Chen,
Raffaele De Caterina,
Wei Feng Shen
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs122
Subject(s) - medicine , coronary artery disease , chromogranin a , cardiology , coronary arteries , stenosis , angiogenesis , artery , immunohistochemistry
We here investigated the endothelial effects of the chromogranin A-derived peptide vasostatin-2 and its relation to coronary artery disease (CAD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom